Dietary supplements quality analysis tools from the United States Pharmacopeia

Drug Testing and Analysis

Volumn 8, Issue 3-4, 2016, Pages 418-423

  Sarma, Nandakumara ^a   Giancaspro, Gabriel ^a   Venema, Jaap ^a  

^a UNITED STATES PHARMACOPEIA   (United States)

Author keywords

Adulteration; Dietary Supplements; DSHEA; Good Manufacturing Practices; PDE5; USP NF

Indexed keywords

FOOD ADDITIVES; NUTRITION; PUBLIC ADMINISTRATION; PUBLIC HEALTH; REGULATORY COMPLIANCE; SPECIFICATIONS; VITAMINS;

'CURRENT; ADULTERATION; ANALYSIS TOOLS; DIETARY SUPPLEMENT HEALTH AND EDUCATION ACT; GOOD MANUFACTURING PRACTICES; PDE5; QUALITY SPECIFICATIONS; UNITED STATE PHARMACOPEIAL CONVENTION-NF; UNITED STATES FOOD AND DRUG ADMINISTRATIONS; UNITED STATES PHARMACOPEIAS;

DIETARY SUPPLEMENTS;

ATHLETIC PERFORMANCE; CHEMICAL COMPOSITION; DIET SUPPLEMENTATION; FOOD AND DRUG ADMINISTRATION; GOOD MANUFACTURING PRACTICE; HUMAN; MARKETING; MEDICAL LITERATURE; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; RESPONSIBILITY; SAFETY; UNITED STATES; WEIGHT REDUCTION; DIETARY SUPPLEMENT; DRUG CONTAMINATION; PREVENTION AND CONTROL; QUALITY CONTROL; STANDARDS;

DIETARY SUPPLEMENTS; DRUG CONTAMINATION; HUMANS; PHARMACOPOEIAS AS TOPIC; PUBLIC HEALTH; QUALITY CONTROL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84958825053     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1940     Document Type: Note

References (39)

1. Nutrition Business Journal, Penton Media Inc. NBJ's Global Supplement & Nutrition Industry Report, New Hope Natural Media, Boulder, Colorado, USA, 2014, pp. 39.
2. DOJ. Justice department and federal partners announce enforcement actions of dietary supplement cases. Available at: http://www.justice.gov/opa/pr/justice-department-and-federal-partners-announce-enforcement-actions-dietary-supplement-cases [23 November 2015].
3. FDA. Letter to manufacturers of dietary supplements. Dr. Margaret Hamburg. Dec 15, 2010. Available at: http://www.fda.gov/downloads/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/MedicationHealthFraud/UCM236985.pdf [06 August 2015].
4. K. C. Klontz, H. J. DeBeck, P. LeBlanc, K. M. Mogen, B. J. Wolpert, J. L. Sabo, M. Salter, S. L. Seelman, S. E. Lance, C. Monahan, D. S. Steigman, K. Gensheimer . The role of adverse event reporting in the FDA response to a multistate outbreak of liver disease associated with a dietary supplement. Public Health Rep. 2015, 130, 526.
5. P. A. Cohen . Hazards of hindsight-monitoring the safety of nutritional supplements. N. Engl. J. Med. 2014, 370, 1277.
6. P. Gardiner, D. N. Sarma, T. Low Dog, M. L. Barrett, M. L. Chavez, R. Ko, G. B. Mahady, R. J. Marles, L. S. Pellicore, G. I. Giancaspro . The state of dietary supplement adverse event reporting in the United States. Pharmacoepidemiol. Drug Saf. 2008, 17, 962.
7. FDA. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. 21 CFR 111. [Docket No. 1996N-0417]. Available at: http://www.fda.gov/ohrms/dockets/98fr/cf0441.pdf p. 400 [6 August 2015].
8. R. K. Miller, C. Celestino, G. I. Giancaspro, R. L. Williams . FDA's dietary supplement GMPs: standards without standardization. Food Drug Law J. 2008, 63, 929.
9. J. Long . More supplement manufacturers complying with FDA GMP regulations, but room for improvement. Available at: http://www.naturalproductsinsider.com/blogs/supplement-law/2015/03/more-supplement-manufacturers-complying-with-fda.aspx [13 November 2015].
10. FDA Warning Letter. Available at: http://www.fda.gov/iceci/enforcementactions/warningletters/2014/ucm406488.htm [6 August 2015].
11. FDA lab testing finds N-acetyl-leucine in samples of recalled Medisca product labeled as L-citrulline. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm385964.htm [6 August 2015].
12. A. O'Conner . Retailers are warned over herbal supplements. The New York Times, 2015, February 3. Available at: http://www.nytimes.com/interactive/2015/02/02/health/herbal_supplement_letters.html [6 August 2015].
13. D. P. Little . Authentication of Ginkgo biloba herbal dietary supplements using DNA barcoding. Genome. 2014, 57, 513.
14. DMAA in Dietary Supplements. Available at: http://www.fda.gov/Food/DietarySupplements/QADietarySupplements/ucm346576.htm [6 August 2015].
15. P.A. Cohen, C. Bloszies, C. Yee, R. Gerona . An amphetamine isomer whose efficacy and safety in humans has never been studied, β-methylphenylethylamine (BMPEA), is found in multiple dietary supplements. Drug Test. Anal. 2015. DOI: 10.1002/dta.1793. [Epub ahead of print].
16. B. J. Venhuis, D. de Kaste . Towards a decade of detecting new analogues of sildenafil, tadalafil and vardenafil in food supplements: a history, analytical aspects and health risks. J. Pharm. Biomed. Anal. 2012, 69, 196.
17. D. N. Patel, L. Li, C. L. Kee, X. Ge, M. Y. Low, H. L. Koh . Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges. J. Pharm. Biomed. Anal. 2014, 87, 176.
18. B.J. Venhuis, M.E. Zwaagstra, J.D.J. van den Berg, H.W.G. Wagenaar, A.J.H.P. van Riel, D. M. Barends, D. de Kaste . Trends in drug substances detected in illegal weight-loss medicines and dietary supplements. A 2002-2007 survey and health risk analysis. RIVM Report 370030002/2009. Available at: http://vorige.nrc.nl/multimedia/archive/00213/370030002_213599a.pdf [6 August 2015].
19. M. Thevis, T. Kuuranne, H. Geyer, W. Schänzer . Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test. Anal. 2015, 7, 1.
20. P. L. Schiff Jr., V. S. Srinivasan, G. I. Giancaspro, D. B. Roll, J. Salguero, M. H. Sharaf . The development of USP botanical dietary supplement monographs, 1995-2005. J. Nat. Prod. 2006, 69, 464.
21. USP Admission Criteria and Safety Classification for Dietary Supplements Guideline. Available at: http://www.usp.org/sites/default/files/usp_pdf/EN/dietarySupp/admissiondsguideline_vers_1.1.pdf [6 August 2015].
22. FDA MedWatch. Available at: http://www.fda.gov/Safety/MedWatch/default.htm [6 August 2015].
23. Dietary Supplements Label Database - Preamble. Available at: http://ods.od.nih.gov/Research/Dietary_Supplement_Label_Database.aspx [6 August 2015].
24. Dietary Supplements Label Database - Ginkgo products. Available at: http://www.dsld.nlm.nih.gov/dsld/rptQSearch.jsp?item=ginkgo&db=adsld [6 August 2015].
25. Federal Food Drug Cosmetic Act. § 201(j); 21 U.S.C. § 321(j). Available at: http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/FDCActChaptersIandIIShortTitleandDefinitions/ucm086297.htm [6 August 2015].
26. USP Ginkgo monographs. USP 38, United States Pharmacopeial Convention, Rockville, MD, 2015, pp. 6061.
27. J. M. Harnly, D. Luthria, P. Chen . Detection of adulterated Ginkgo biloba supplements using chromatographic and spectral fingerprints. J. AOAC Int. 2012, 95, 1579.
28. A. Bzhelyansky, N. D. Sarma, G. I. Giancaspro . Letter to the Editor in response to 'Adulteration of Ginkgo biloba products and a simple method to improve its detection' by Wohlmuth et al. Phytomedicine. 2014, 21, 1497.
29. T. A. van Beek, P. Montoro . Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals. J. Chromatogr. A. 2009, 1216, 2002.
30. FDA. Warning letter to Iowa Select Herbs 4/18/14. Available at: http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2014/ucm394259.htm [06 August 2015.
31. B. Avula, S. Sagi, S. Gafner, R. Upton, Y. H. Wang, M. Wang, I. A. Khan . Identification of Ginkgo biloba supplements adulteration using high performance thin layer chromatography and ultra high performance liquid chromatography-diode array detector-quadrupole time of flight-mass spectrometry. Anal. Bioanal. Chem. 2015, 407, 7733.
32. USP. The United States Pharmacopeial Convention urges scientific validation of DNA test methods for regulating the quality of herbal supplements. Available at: http://www.usp.org/news/united-states-pharmacopeial-convention-urges-scientific-validation-dna-test-methods-regulating-quality-herbal-supplements. [6 August 2015].
33. NIH. Office of Dietary Supplements - Analytical methods and reference materials program. Available at: https://ods.od.nih.gov/Research/AMRMProgramWebsite.aspx [23 November 2015].
34. FDA. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. 21 CFR 111. [Docket No. 1996N-0417]. Available at: http://www.fda.gov/ohrms/dockets/98fr/cf0441.pdf; pp 402 and 563 [6 August 2015].
35. USP. <1225> Validation of Compendial Procedures. USP 38. In: USP 38-NF 33. United States Pharmacopeial Convention, Rockville, MD, 2015, pp. 1445.
36. USP Dietary Supplements Verification Program. Available at: http://www.usp.org/usp-verification-services [6 August 2015].
37. USP. <2251> Adulteration of dietary supplements with drugs and drug analogs. Pharmacopeial Forum, 2014, 41(3). United States Pharmacopeial Convention, Rockville, MD.
38. USP. Food Fraud Database. Available at: http://www.usp.org/food-ingredients/food-fraud-database [6 August 2015].
39. J. C. Moore, J. Spink, M. Lipp . Development and application of a database of food ingredient fraud and economically motivated adulteration from 1980 to 2010. J. Food Sci. 2012, 77, R118.